Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Era Mandiri Cemerlang Tbk. (IKAN) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance

Era Mandiri Cemerlang Tbk.Trade
Prodia Diagnostic Line TbkTrade

Price performance (Past 24H)

Key statistics

Era Mandiri Cemerlang Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp90 (market cap 75.83B, 8.23M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 5.7× Era Mandiri Cemerlang Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 8.23M). Which is the better fit depends on your goals.

IKANPRDL
Market Cap
75.83B428.75B
Volume
8.23M13.83M
Lot
82.29K138.27K
Turnover
741.24M3.27B
Average Price
90.07236.62
Value
741.24M3.27B
Indicative Equilibrium Price
90236
Indicative Equilibrium Volume
3111.74K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IKAN
View details
PRDL
View details

About Era Mandiri Cemerlang Tbk.

PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.

Read more on IKAN

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL